Product NDC: | 60505-2545 |
Proprietary Name: | Zonisamide |
Non Proprietary Name: | Zonisamide |
Active Ingredient(s): | 25 mg/1 & nbsp; Zonisamide |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-2545 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077642 |
Marketing Category: | ANDA |
Start Marketing Date: | 20051222 |
Package NDC: | 60505-2545-6 |
Package Description: | 60 CAPSULE in 1 BOTTLE (60505-2545-6) |
NDC Code | 60505-2545-6 |
Proprietary Name | Zonisamide |
Package Description | 60 CAPSULE in 1 BOTTLE (60505-2545-6) |
Product NDC | 60505-2545 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Zonisamide |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20051222 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | ZONISAMIDE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |